Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A3 pseudogene 13 (HNRNPA3P13) is a processed pseudogene—a non-functional duplicate—of the HNRNPA3 gene, located in the human genome[3][7][8]. Pseudogenes like HNRNPA3P13 do not produce functional proteins and do not have characterized biological functions, disease relevance, or drug interactions[5]. The canonical protein, heterogeneous nuclear ribonucleoprotein A3 (HNRNPA3), is a member of the hnRNP A/B RNA-binding protein family involved in pre-mRNA processing and has documented links to cancer biology and cellular processes[2][4][6]. However, HNRNPA3P13 itself is not a receptor, enzyme, or other molecular target of therapeutic interest; it is simply one of many pseudogenic copies in the genome, with no evidence of protein-coding or direct biological activity[5][3][7][8]. Assessment: - HNRNPA3P13 is a pseudogene, not a functional molecular target, and therefore not relevant for drug targeting or biomarker purposes[5][3][7][8]. - This entry is incorrect for most drug discovery or therapeutic contexts where "target" refers to a functional protein, receptor, enzyme, or other biomolecule of interest—unless specifically studying pseudogene regulation or evolutionary genomics. - For information related to molecular targets, the functional gene HNRNPA3, not its pseudogenes, should be considered.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 13 (HNRNPA3P13).